Seer (NASDAQ:SEER – Get Free Report) is anticipated to announce its Q3 2026 results after the market closes on Tuesday, November 10th. Analysts expect the company to announce earnings of ($0.26) per share and revenue of $4.15 million for the quarter. Investors can check the company’s upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Tuesday, November 10, 2026 at 4:30 PM ET.
Seer (NASDAQ:SEER – Get Free Report) last released its quarterly earnings data on Tuesday, August 11th. The company reported ($0.31) EPS for the quarter, missing the consensus estimate of ($0.27) by ($0.04). The business had revenue of $3.10 million during the quarter, compared to the consensus estimate of $3.55 million. Seer had a negative return on equity of 27.23% and a negative net margin of 478.05%.
Seer Stock Performance
SEER opened at $1.73 on Tuesday. The stock has a market capitalization of $95.79 million, a P/E ratio of -1.42 and a beta of 1.47. The company’s 50-day simple moving average is $2.00 and its two-hundred day simple moving average is $1.92. Seer has a 52-week low of $1.55 and a 52-week high of $2.38.
Analyst Ratings Changes
Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Seer in a research note on Thursday, October 15th. Two research analysts have rated the stock with a Strong Buy rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Buy” and a consensus price target of $4.00.
Check Out Our Latest Stock Analysis on SEER
About Seer
Seer, Inc is a life sciences company that develops technologies for large-scale protein analysis, known as proteomics. The company’s platform is designed to help researchers study a broad range of proteins in biological samples and generate detailed information that may support drug discovery, disease research and biomarker development.
Seer’s primary offering is the Proteograph Product Suite, which combines engineered nanoparticle technology, laboratory consumables, automation and software.
Further Reading
- Five stocks we like better than Seer
- AST SpaceMobile’s Brazil Breakthrough Could Set the Stage for a Q3 Stock Rebound
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
Receive News & Ratings for Seer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Seer and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png){kind=logo}
